feed,title,long_url,short_url
Benzinga,Mizuho On Atara Biotherapeutics - Distinguish Between Small Numbers And Science Failure,https://benzinga.com/analyst-ratings/analyst-color/22/07/28053736/mizuho-on-atara-biotherapeutics-distinguish-between-small-numbers-and-science-failu,https://bit.ly/3P1hb1s
Benzinga,Oncocyte Enters $2B Market With Transplant Rejection Monitoring Test,https://benzinga.com/news/22/07/28052174/oncocyte-enters-2b-market-with-transplant-rejection-monitoring-test,https://bit.ly/3cbpTMe
